TradeFlare's AI research teams analysed IMVT on 5 market nights between April 14, 2026 and September 1, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| September 1, 2026 | BUY | $40.82 | $47.95 / $34.69 | -2.9% | -15.3% | The setup suggests a short-term bounce opportunity driven by technical oversold conditions and positive sentiment, with the potential for further upside if fundamental catalysts materialize. |
| August 31, 2026 | BUY | $41.20 | $47.38 / $34.92 | -3.1% | -18.0% | The technical setup suggests a short-term bounce opportunity, while the fundamental and sentiment are bullish for a medium-term move. |
| June 23, 2026 | BUY | $38.10 | $43.82 / $32.39 | +2.4% | +3.8% | The stock is exhibiting strong momentum and is poised for a breakout, aligning with the technical and fundamental bullish outlooks. |
| May 20, 2026 | HOLD | $26.29 | — / — | -5.8% | -0.6% | Positive clinical trial data for IMVT-1402. |
| April 14, 2026 | BUY | $25.12 | $40.12 / $18.50 | +6.5% | +7.9% | The fundamental analysis suggests a long-term potential based on clinical trial progress and analyst targets, despite the current negative sentiment. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.